Pi Health, an AI startup focusing on cancer treatment trials, has raised over $30 million in funding. The funds will be used to further develop its technology and establish new partnerships. The Cambridge, Massachusetts-based startup was incubated as a subsidiary of Nasdaq-listed BeiGene Ltd and is now launching as an independent company. Pi Health’s platform assists clinical trial researchers in recruiting cancer patients from the US, Brazil, Australia, and India. The company uses AI to automate tasks such as matching patients with trials, clinical documentation, and monitoring adverse events during studies. The founders plan to build their own foundational AI system.
Read more at: www.bloomberg.com